Yeungnam University College Of Medicine
Clinical trials sponsored by Yeungnam University College Of Medicine, explained in plain language.
-
New eye drug regimen aims to cut injection frequency for PCV patients
Disease control Recruiting nowThis study tests a personalized treat-and-extend approach using faricimab for people newly diagnosed with polypoidal choroidal vasculopathy (PCV), a form of wet age-related macular degeneration. The goal is to see if this regimen can safely extend the time between eye injections …
Phase: PHASE3 • Sponsor: Yeungnam University College of Medicine • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
New eye drug regimen could mean fewer shots for PCV patients
Disease control Recruiting nowThis study tests a higher dose (8 mg) of the drug aflibercept, given on a personalized schedule, for people with a specific eye condition called polypoidal choroidal vasculopathy (PCV) that has not been treated before. The goal is to see if this approach can keep the disease unde…
Phase: PHASE3 • Sponsor: Yeungnam University College of Medicine • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC